Skip to main content
. Author manuscript; available in PMC: 2019 Aug 9.
Published in final edited form as: Biomed Microdevices. 2018 Dec 6;20(4):100. doi: 10.1007/s10544-018-0348-7

Table 1.

Intact skin concentrations (μmol drug/g skin) of propranolol and timolol under various dosing regimens (n=3)

Study Drug application Study length Skin concentrations (μmol drug/g skin)
Propranolol Timolol
Single dose study At the beginning of the study 24 hours 4.82 ± 1.45 1.91 ± 0.35
36 hours 3.45 ± 0.77 1.56 ± 0.29
48 hours 3.22 ± 0.85 1.77 ± 0.16
72 hours 2.53 ± 0.87 1.41 ± 0.08
Once a day study Every 24 hours 24 hours 4.82 ± 1.45 1.91 ± 0.35
48 hours 9.17 ± 3.27 4.00 ± 0.95
72 hours 14.41 ± 1.28 3.33 ± 0.49
Twice a day study Every 12 hours 24 hours 5.66 ± 0.61 1.57 ± 0.80
36 hours 10.92 ± 0.71 1.63 ± 0.60
48 hours 14.54 ± 2.36 1.27 ± 0.09